
J&J reports $100M in sales of COVID-19 vaccine
NY Post
Health care giant Johnson & Johnson reported strong first-quarter numbers, boosted by sales of its one-dose COVID-19 vaccine — despite the shot currently being on pause in the United States.
J&J reported a first-quarter net income of $6.2 billion ($2.32 per share), which included $100 million from sales of the COVID-19 vaccine, according to the Associated Press. That is up 6.9 percent from $5.8 billion ($2.17 per share) from the same time last year.More Related News

Gas prices reach highest level since October 2023 as oil holds above $100 per barrel; US stocks jump
Brent crude oil held above $100 per barrel on Monday, pushing national average gasoline prices to their highest level since October 2023 as President Trump urged allies to help protect oil tankers from Iranian attacks in the key Strait of Hormuz.












